Matthew Bryant

Antitumor activity of SCH 66336, an orally bioavailable tricyclic inhibitor of farnesyl protein transferase, in human tumor xenograft models and wap-ras transgenic mice.

Ming Liu, Matthew Bryant, Jianping Chen et al. · PubMed · 1998 · 309 citations

Sch 66336, Chemoprevention Strategy, Farnesyl Protein Transferase +15

Hemoglobin adducts of 4-aminobiphenyl in smokers and nonsmokers.

Matthew Bryant, Paul L. Skipper, Steven R. Tannenbaum et al. · PubMed · 1987 · 256 citations

Tobacco Control, Respiratory Toxicology, Nicotine +19

Hemoglobin adducts of aromatic amines: associations with smoking status and type of tobacco.

Matthew Bryant, Paolo Vineis, Paul L. Skipper et al. · Proceedings of the National Academy of Sciences · 1988 · 192 citations · Full text

Tobacco Control, Hemoglobin Adducts, Smoking Status +10

Toxicity Evaluation of Bisphenol A Administered by Gavage to Sprague Dawley Rats From Gestation Day 6 Through Postnatal Day 90

K. Barry Delclos, Luísa Camacho, Sherry M. Lewis et al. · Toxicological Sciences · 2014 · 163 citations · Full text

Randomized Phase II Study of Paclitaxel plus Alisertib versus Paclitaxel plus Placebo as Second-Line Therapy for SCLC: Primary and Correlative Biomarker Analyses

Taofeek K. Owonikoko, Huifeng Niu, Kristiaan Nackaerts et al. · Journal of Thoracic Oncology · 2019 · 141 citations · Full text